ProShares UltraShort NASDAQ Biotechnology
13 hedge funds and large institutions have $2.62M invested in ProShares UltraShort NASDAQ Biotechnology in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
2
Reduced
3
Closed
3
Calls
$5.21M
Puts
–
Net Calls
+$5.21M
Net Calls Change
+$3.45M
